Our genome data are safe

We store the patient genome data in a specially designed encrypted server that is not affected by the security problems experienced with the OUS hospital system

Read more

NCG arranges meeting on a Nordic model for personalized medicine

You can see video from the plenary sessions from the pages of our partner The Biotechnology Advisory Board

Read more

The NCGC initiative gets international attention

The project is commented in Nature, Lancet etc

Read more

What is personalized cancer treatment?

Cancer is an extremely complex disease, and we traditionally categorize cancers with names indicative of the tissue the cancer is situated in, or alternatively is similar to (e.g. breast cancer, colon cancer, lung cancer, etc.) However, a tumour classed within one cancer group (e.g. lung cancer) can often be very different from another lung cancer tumour. Instead, tumours can share genetic similarities with tumours classed in other cancer groups.

Read more

NCGC participates in bioinformatics benchmarking and implements consensus mutation analyses

Several NCGC groups are involved in the International cancer Genomics Consortium, and our bioinformatics team, led by Eivind Hovig, has participated in the ICGC bioinformatics benchmarking study to provide us with international consensus pipelines for mutation scoring

Read more

Norwegian 1000 genomse project

We have extracted all single germline variants in our patient cohort, and present their frequencies in a public database. This will benefit other researchers and clinicians needing to know if a rare variant is seen more commonly in the Norwegian population

Read more